Skip to main content
  • GlycoT Therapeutics Grants Sublicense to Daiichi Sankyo

    The agreement provides worldwide, non-exclusive rights to two pieces of University of Maryland, Baltimore technology as well as two pieces of University of Maryland, College Park technology.

    Read more
  • CoapTech Raises $7M Series B Round

    Led by medical device venture capital firm Hunniwell Lake Ventures, CoapTech will use funds to commercialize its ultrasound-based feeding tube placement system.

    Read more
  • Pumas 1.0 is here!

    Developed by Pumas-AI, the pharmaceutical modelling and simulation platform launched on Aug. 11.

    Read more
  • UMSOM Startup Protaryx Raises $8.3M Funding Round

    Co-founded by Dr. James Gammie, co-founder and inventor for Harpoon Medical, Protaryx is developing a device for left atrial access in transcatheter cardiac procedures.

    Read More
  • Developing and Commercializing a Medical Device

    We sat down with Jon Wu, the engineer and co-inventor of Breethe’s novel technology, and with Phil Robilotto, UMB Associate Vice President of the Office of Technology Transfer, to learn more about Breethe and the critical role...

    Read More
  • UM Ventures-Backed Startup Breethe Acquired by Abiomed

    The first-of-its-kind portable artificial lung will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation.

    Read the story
  • Y Combinator-Backed GEn1E Lifesciences Licenses UMB Drug Portfolio Compound

    GEn1E is developing cures for inflammatory diseases based on a next-generation p38a kinase inhibitor program.

    Read the story

Spotlight on...

UM Ventures has launched a series of initiatives for the Center for Maryland Advanced Ventures, including:

NEW ACCELERATOR: Trajectory Next
Trajectory Next is a 12-week post-accelerator program for digital health, bio-health, and life sciences startups.


The Baltimore Fund
The Baltimore Fund provides financial incentives to companies affiliated with Maryland Public Higher Education Institutions to locate in a network of innovation centers in Baltimore City.


The UMCP Fischell Institute
The UMCP Fischell Institute for Biomedical Devices is opening a satellite location at UMB to accelerate the development of innovative medical devices.


Maryland Momentum Fund
The University System of Maryland created the Maryland Momentum Fund, a $25 million early-stage investment program investing in USM-affiliated companies. The Maryland Momentum Fund is staffed by UM Ventures.


University of Maryland, Baltimore Institute for Clinical and Translational Research
The University of Maryland, Baltimore Institute for Clinical and Translational Research (ICTR) is pleased to announce the first round of UMB ICTR Accelerated Translational Incubator Pilot (ATIP) Grant funding opportunities for 2018-2019.

VIEW MORE

University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More